NVO 241227 109.00C (NVO241227C109000) Stock Options, News & Quotes

0.04
+0.02+100.00%

15min DelayClose Dec 23 16:00 ET

0.04High0.04Low

SymbolStock Name

PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

pootpoot

15 hours ago

$Novo-Nordisk A/S (NVO.US)$
it was fun..

Share Your Profit/Loss

Movers and Shakers

16 hours ago

Columns Today's Pre-Market Movers and Top Ratings | NVO, TSLA, TRAW and More

Morning Movers
Gapping up
$Novo-Nordisk A/S (NVO.US)$ shares rose 5%, recovering from an 18% drop in the previous session after its weight loss drug, CagriSema, posted disappointing late-stage trial results on Friday.
$Tesla (TSLA.US)$ gained 3% premarket, recovering from last week's 3.5% drop, its worst performance since before the U.S. presidential election.
$Traws Pharma (TRAW.US)$ shares surged 109% after announcing progress on...

Money Thrill

16 hours ago

What to understand about statistics ?

$Novo-Nordisk A/S (NVO.US)$ Statistics are always open to interpretation. Never a 100 percent correct evaluation. In doing so, Novo also point out a number of RESEARCH LIMITATIONS. Less than SIX out of TEN obese patients would have used the highest permitted dose. Nevertheless, Novo Nordisk will ask the regulators of the pharmaceutical industry to allow the drug for commercialization.
So, would you care if a weight loss supplement only achieved a 22.7% weight ...

Ho Lee Fuk

21 hours ago

$Novo-Nordisk A/S (NVO.US)$ 150 by this year

102532025

21 hours ago

$Novo-Nordisk A/S (NVO.US)$ why the drop